Randomized Study on Neoadjuvant Radio-Chemotherapy in Rectal Carcinoma Dukes B and C
A Prospectively Randomized Study on Neoadjuvant Radio-Chemotherapy in Patients With Operated Rectal Carcinoma Dukes B and C (pT2, pN1-3; pT3-4, pN0-3; M0.
Sponsor: Austrian Breast & Colorectal Cancer Study Group
Terminated
This trial was terminated. No reason was provided.
A PHASE3 clinical study on Rectal Cancer Dukes B, Dukes C, this trial is terminated or withdrawn. The trial is conducted by Austrian Breast & Colorectal Cancer Study Group and has accumulated 6 data snapshots since 1997. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
6 versions recorded-
Jan 2026 — Present [monthly]
Terminated PHASE3
-
Sep 2025 — Present [monthly]
Terminated PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE3
▶ Show 1 earlier version
-
Jan 2017 — Jan 2021 [monthly]
Terminated PHASE3
First recorded
Jul 1997
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Austrian Breast & Colorectal Cancer Study Group
For direct contact, visit the study record on ClinicalTrials.gov .